Immutep Limited logo
Immutep Limited IMMP
$ 0.31 -1.56%

Annual report 2025
added 04-11-2026

report update icon

Immutep Limited P/S Ratio 2011-2026 | IMMP

Annual P/S Ratio Immutep Limited

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 492 7.63 7.76 6.57 - 526 - - - 122 -

All numbers in AUD currency

Indicator range from annual reports

Maximum Minimum Average
526 6.57 194

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Aligos Therapeutics Aligos Therapeutics
ALGS
30.2 $ 8.64 8.07 % $ 85.4 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.66 -1.48 % $ 8.81 B australiaAustralia
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Applied Therapeutics Applied Therapeutics
APLT
54.1 - - $ 8.42 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.73 $ 21.36 4.86 % $ 998 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
1.42 $ 1.47 5.0 % $ 378 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 2.92 - $ 4.81 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
10.5 $ 4.19 2.7 % $ 448 M usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
9.15 $ 24.12 -0.37 % $ 3.07 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.32 K $ 32.59 1.09 % $ 2.16 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.47 -1.34 % $ 391 M britainBritain
Cidara Therapeutics Cidara Therapeutics
CDTX
116 - - $ 1.41 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
11.2 - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
2.17 - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
Esperion Therapeutics Esperion Therapeutics
ESPR
1.39 $ 2.22 2.3 % $ 461 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
71.3 $ 0.82 1.13 % $ 27.9 M israelIsrael
Baudax Bio Baudax Bio
BXRX
0.614 - 0.59 % $ 63 K usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.3 M $ 3.2 2.24 % $ 322 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
110 - - $ 3.45 B usaUSA